Similar articles for PMID: 34972717

Year	Number of Results
2002	1
2005	2
2006	7
2007	1
2008	2
2009	4
2010	5
2011	5
2012	4
2013	4
2014	6
2015	11
2016	9
2017	9
2018	8
2019	7
2020	11
2021	7
2022	2
2023	0

1

Hypoxia-induced Maspin Expression Affects the Prognosis of Ovarian Clear Cell Carcinoma.

Lee EJ, Park SJ, Lee C, Yim GW, Kim JW, Kim HS. Lee EJ, et al. In Vivo. 2022 Jan-Feb;36(1):212-220. doi: 10.21873/invivo.12693. In Vivo. 2022. PMID: 34972717 Free PMC article.

2

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma.

Zhou H, Liu Q, Shi X, Liu Y, Cao D, Yang J. Zhou H, et al. J Ovarian Res. 2020 Apr 15;13(1):38. doi: 10.1186/s13048-020-00641-8. J Ovarian Res. 2020. PMID: 32295618 Free PMC article.

3

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.

Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LJ, Tewari K, Argenta PA, Mannel RS, Secord AA, Stephan JM, Mutch DG, Stehman FB, Muggia FM, Rose PG, Armstrong DK, Bookman MA, Burger RA, Farley JH. Oliver KE, et al. Gynecol Oncol. 2017 Nov;147(2):243-249. doi: 10.1016/j.ygyno.2017.08.004. Epub 2017 Aug 12. Gynecol Oncol. 2017. PMID: 28807367 Free PMC article.

4

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.

Tan TZ, Ye J, Yee CV, Lim D, Ngoi NYL, Tan DSP, Huang RY. Tan TZ, et al. EBioMedicine. 2019 Dec;50:203-210. doi: 10.1016/j.ebiom.2019.11.017. Epub 2019 Nov 21. EBioMedicine. 2019. PMID: 31761620 Free PMC article.

5

Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma.

Suzuki H, Yano M, Miyazawa M, Miyazawa M, Ogane N, Hasegawa K, Tsuda H, Yoshida M, Okagaki R, Ishihara O, Yasuda M. Suzuki H, et al. J Ovarian Res. 2019 Jan 24;12(1):7. doi: 10.1186/s13048-019-0481-9. J Ovarian Res. 2019. PMID: 30678691 Free PMC article.

6

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

Makii C, Oda K, Ikeda Y, Sone K, Hasegawa K, Uehara Y, Nishijima A, Asada K, Koso T, Fukuda T, Inaba K, Oki S, Machino H, Kojima M, Kashiyama T, Mori-Uchino M, Arimoto T, Wada-Hiraike O, Kawana K, Yano T, Fujiwara K, Aburatani H, Osuga Y, Fujii T. Makii C, et al. Oncotarget. 2016 Nov 15;7(46):75328-75338. doi: 10.18632/oncotarget.12175. Oncotarget. 2016. PMID: 27659536 Free PMC article.

7

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.

Gynecologic Oncology Group; Secord AA, Lee PS, Darcy KM, Havrilesky LJ, Grace LA, Marks JR, Berchuck A. Gynecologic Oncology Group, et al. Gynecol Oncol. 2006 Jun;101(3):390-7. doi: 10.1016/j.ygyno.2006.02.014. Epub 2006 Mar 21. Gynecol Oncol. 2006. PMID: 16551475

8

Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma.

Chao A, Lai CH, Wang TH, Jung SM, Lee YS, Chang WY, Yang LY, Ku FC, Huang HJ, Chao AS, Wang CJ, Chang TC, Wu RC. Chao A, et al. J Mol Med (Berl). 2018 Jun;96(6):527-536. doi: 10.1007/s00109-018-1643-8. Epub 2018 May 3. J Mol Med (Berl). 2018. PMID: 29725737

9

Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma.

Wang H, Tan M, Zhang S, Li X, Gao J, Zhang D, Hao Y, Gao S, Liu J, Lin B. Wang H, et al. Int J Mol Sci. 2015 Feb 4;16(2):3391-404. doi: 10.3390/ijms16023391. Int J Mol Sci. 2015. PMID: 25658794 Free PMC article.

10

Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates.

Surowiak P, Materna V, Drag-Zalesinska M, Wojnar A, Kaplenko I, Spaczyński M, Dietel M, Zabel M, Lage H. Surowiak P, et al. Int J Gynecol Pathol. 2006 Apr;25(2):131-9. doi: 10.1097/01.pgp.0000183050.30212.2f. Int J Gynecol Pathol. 2006. PMID: 16633061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year